BANK VONTOBEL/CALL/ELI LILLY & CO/740/0.1/21.06.24 Share Price

Warrant

DE000VM345C5

Market Closed - Deutsche Boerse AG 11:14:19 14/06/2024 pm IST
13.26 EUR +2.55% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/740/0.1/21.06.24
Current month+80.16%
1 month+271.43%
Date Price Change
14/24/14 13.26 +2.55%
13/24/13 12.93 +8.38%
12/24/12 11.93 +3.83%
11/24/11 11.49 +0.70%
10/24/10 11.41 +4.58%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 11:14 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM345C
ISINDE000VM345C5
Date issued 17/10/2023
Strike 740 $
Maturity 21/06/2024 (5 Days)
Parity 10 : 1
Emission price 2.91
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 14.19
Lowest since issue 0.95
Delta0.95x
Omega 5.904
Premium0.33x
Gearing6.22x
Moneyness 1.187
Difference Strike -138.5 $
Difference Strike %-18.71%
Spread 0.02
Spread %0.15%
Intrinsic value 12.93

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus